BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23372711)

  • 1. Inhibition of P-glycoprotein by HIV protease inhibitors increases intracellular accumulation of berberine in murine and human macrophages.
    Zha W; Wang G; Xu W; Liu X; Wang Y; Zha BS; Shi J; Zhao Q; Gerk PM; Studer E; Hylemon PB; Pandak WM; Zhou H
    PLoS One; 2013; 8(1):e54349. PubMed ID: 23372711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART.
    Lucia MB; Rutella S; Leone G; Vella S; Cauda R
    J Acquir Immune Defic Syndr; 2001 Aug; 27(4):321-30. PubMed ID: 11468419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages.
    Zha W; Liang G; Xiao J; Studer EJ; Hylemon PB; Pandak WM; Wang G; Li X; Zhou H
    PLoS One; 2010 Feb; 5(2):e9069. PubMed ID: 20161729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interactions between 20(S)-ginsenoside Rh2 and the HIV protease inhibitor ritonavir in vitro and in vivo.
    Shi J; Cao B; Zha WB; Wu XL; Liu LS; Xiao WJ; Gu RR; Sun RB; Yu XY; Zheng T; Li MJ; Wang XW; Zhou J; Mao Y; Ge C; Ma T; Xia WJ; Aa JY; Wang GJ; Liu CX
    Acta Pharmacol Sin; 2013 Oct; 34(10):1349-58. PubMed ID: 23892274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory Effect of Berberine on Broiler P-glycoprotein Expression and Function: In Situ and In Vitro Studies.
    Zhang Y; Guo L; Huang J; Sun Y; He F; Zloh M; Wang L
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein expression in HTLV-III cells after treatment with HIV-1 protease inhibitors.
    Sánchez Mdel C; López P; Vélez R; Yamamura Y
    Ethn Dis; 2008; 18(2 Suppl 2):S2-60-4. PubMed ID: 18646322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function.
    Shan YQ; Zhu YP; Pang J; Wang YX; Song DQ; Kong WJ; Jiang JD
    Biol Pharm Bull; 2013; 36(10):1562-9. PubMed ID: 23924821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L; Eagling VA; Back DJ
    AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?
    Jones K; Bray PG; Khoo SH; Davey RA; Meaden ER; Ward SA; Back DJ
    AIDS; 2001 Jul; 15(11):1353-8. PubMed ID: 11504956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of Transmembrane Transport Mechanism Study of Imperatorin on P-Glycoprotein-Mediated Drug Transport.
    Liao ZG; Tang T; Guan XJ; Dong W; Zhang J; Zhao GW; Yang M; Liang XL
    Molecules; 2016 Nov; 21(12):. PubMed ID: 27886150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine.
    Xiong W; Sang W; Linghu KG; Zhong ZF; Cheang WS; Li J; Hu YJ; Yu H; Wang YT
    Int J Nanomedicine; 2018; 13():3781-3793. PubMed ID: 29988733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
    Patel J; Buddha B; Dey S; Pal D; Mitra AK
    Am J Ther; 2004; 11(4):262-77. PubMed ID: 15266218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of human immunodeficiency virus protease inhibitors on multidrug resistance transporter P-glycoproteins.
    Shiraki N; Hamada A; Yasuda K; Fujii J; Arimori K; Nakano M
    Biol Pharm Bull; 2000 Dec; 23(12):1528-31. PubMed ID: 11145192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the HIV protease inhibitor-induced ER stress and inflammatory response by raltegravir in macrophages.
    Zhang X; Cao R; Liu R; Zhao R; Huang Y; Gurley EC; Hylemon PB; Pandak WM; Wang G; Zhang L; Li X; Zhou H
    PLoS One; 2014; 9(3):e90856. PubMed ID: 24625618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pharmacokinetic mechanism of the drug-drug interaction between genistein and repaglinide mediated by P-gp.
    Jin H; Zhu Y; Wang C; Meng Q; Wu J; Sun P; Ma X; Sun H; Huo X; Liu K; Tan A
    Biomed Pharmacother; 2020 May; 125():110032. PubMed ID: 32187961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saquinavir induces stable and functional expression of the multidrug transporter P-glycoprotein in human CD4 T-lymphoblastoid CEMrev cells.
    Dupuis ML; Flego M; Molinari A; Cianfriglia M
    HIV Med; 2003 Oct; 4(4):338-45. PubMed ID: 14525546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line.
    Perloff MD; Von Moltke LL; Marchand JE; Greenblatt DJ
    J Pharm Sci; 2001 Nov; 90(11):1829-37. PubMed ID: 11745741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Oregon grape root extracts on P-glycoprotein mediated transport in
    Fan Y; Zhou Z; Zhang L
    J Pharm Pharm Sci; 2023; 26():11927. PubMed ID: 38304488
    [No Abstract]   [Full Text] [Related]  

  • 19. Transport inhibition of digoxin using several common P-gp expressing cell lines is not necessarily reporting only on inhibitor binding to P-gp.
    Lumen AA; Li L; Li J; Ahmed Z; Meng Z; Owen A; Ellens H; Hidalgo IJ; Bentz J
    PLoS One; 2013; 8(8):e69394. PubMed ID: 23976943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of berberine on proinflammatory M1 macrophage polarization through interfering with the interaction between TLR4 and MyD88.
    Gong J; Li J; Dong H; Chen G; Qin X; Hu M; Yuan F; Fang K; Wang D; Jiang S; Zhao Y; Huang W; Huang Z; Lu F
    BMC Complement Altern Med; 2019 Nov; 19(1):314. PubMed ID: 31744490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.